NewcelX NCEL
NASDAQ NCEL
$3.08 +0.11 (+3.54%)
As of: Sep 30, 2026 · 3:19 PM EDT

NewcelX (NCEL) Retained Earnings (2019 - 2026)

Updated

NewcelX (NCEL) reported Retained Earnings of -$90.48 million for Q2 2026, compared with -$87.73 million a year earlier.

Analysis

NewcelX (NCEL) Retained Earnings (2019 - 2026) Analysis & Trends

At the end of FY2025, NewcelX posted Retained Earnings of -$84.89 million.

  • By year, Retained Earnings came in at -$76.59 million in FY2024, -$69.35 million in FY2023, -$66.08 million in FY2022 and -$41.71 million in FY2021.
  • The Q2 2026 figure ranks as the lowest quarterly Retained Earnings in data going back to Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 171.67 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -17.33 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 63.27 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 40.86 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 12.59 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn -22.28 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 2.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 112.09 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 15.69 Bn
10 NewcelX 11.42 Mn 11.42 Mn - -90.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -90.48 Mn
Dec 31, 2025 -84.89 Mn
Jun 30, 2025 -87.73 Mn
Dec 31, 2024 -76.59 Mn
Jun 30, 2024 -70.58 Mn
Dec 31, 2023 -69.35 Mn
Jun 30, 2023 -68.00 Mn
Dec 31, 2022 -66.08 Mn
Jun 30, 2022 -50.35 Mn
Dec 31, 2021 -41.71 Mn
Jun 30, 2021 -34.36 Mn
Dec 31, 2020 -29.76 Mn
Dec 31, 2019 -26.90 Mn
API Access

NewcelX Retained Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=retained-earnings&ticker=NCEL&period=max&api_key=YOUR_API_KEY